Ingelheim Am Rhein, Rheinland-Pfalz, Germany Boehringer Ingelheim appeared to be the Corporate Investor, which was created in 1885. The venture was found in Europe in Germany. The leading representative office of defined Corporate Investor is situated in the Ingelheim Am Rhein.
The typical case for the fund is to invest in rounds with 2 participants. Despite the Boehringer Ingelheim, startups are often financed by Vesalius Biocapital Partners, Shire, S.R.I.W.. The meaningful sponsors for the fund in investment in the same round are Shire, SFPI-FPIM, PPF Group. In the next rounds fund is usually obtained by Vesalius Biocapital Partners, Shinsei Corporate Investment Limited, Shibuya Kogyo.
The top activity for fund was in 2018. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2018.
The fund has exact preference in some founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Therapeutics, Medical. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight MabVax Therapeutics, Promethera Biosciences. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.
| Fund Name | Location |
| Andrew Carter Capital | Dallas, Texas, United States |
| Asigin Research institute Ltd. | Japan, Tochigi Prefecture, Utsunomiya |
| Beamonte Investments | Boston, Massachusetts, United States |
| BSKG Holdings | - |
| Council Capital | Nashville, Tennessee, United States |
| Debiopharm Innovation Fund | Lausanne, Switzerland, Vaud |
| Discovery Alliance LLC | Austin, Texas, United States |
| Edgecrest Capital Corporation | Canada, Ontario, Toronto |
| Genstar Capital | California, San Francisco, United States |
| Liangjiang Xu Hui Zichan Guanli Zhongxin | China, Chongqing, Chongqing Shi |
| Liberty Digital | California, Los Angeles, United States |
| MS Direct Group | Kreuzlingen, Sankt Gallen, Switzerland |
| Proxy Ventures | England, London, United Kingdom |
| QUI! GROUP | Genova, Italy, Liguria |
| SeedCapital Dortmund | Dortmund, Germany, Nordrhein-Westfalen |
| Sirios Capital Management | Boston, Massachusetts, United States |
| StratMinds | California, San Francisco, United States |
| Taya Investment Company Ltd | - |
| TDH Capital | Pennsylvania, Radnor, United States |
| Visit Intelligence Oy | Finland, Parainen, Southwest Finland |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TeleVet | $43M | 31 Aug 2023 | Austin, Texas, United States | ||
NBE-Therapeutics | $22M | 10 Jan 2020 | Basel, Basel-City, Switzerland | ||
Greybox Solutions | 01 Jan 2018 | Montreal, Quebec, Canada | |||
Promethera Biosciences | $29M | 25 Nov 2014 | Walloon Brabant |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TeleVet | $43M | 31 Aug 2023 | Austin, Texas, United States | ||
NBE-Therapeutics | $22M | 10 Jan 2020 | Basel, Basel-City, Switzerland | ||
Greybox Solutions | 01 Jan 2018 | Montreal, Quebec, Canada | |||
Promethera Biosciences | $29M | 25 Nov 2014 | Walloon Brabant |
